The Agents section of the Lymphoma Hub profiles emerging new therapeutic agents for the treatment of lymphoma and CLL, examining mechanisms of action, providing an overview of the drug class and currently available data. Click on the arrow next to the class you are interested in to show more information. Click on the agent’s name in the graph to view the detailed analysis.
Please note that this page is currently under development. Check back regularly to learn more about:
- Inhibitors of EGFR; HER2; hsp90; IAP; NEDD8-activating enzyme; and CDK
- Naked and conjugated monoclonal antibodies